NCT05227417Completed
A Mobile Phone SMS Intervention to Increase Retention in HIV Care Among HIV-Positive MSM in Peru (WELTEL PERU)
A Mobile Phone Short Message Service Intervention to Increase Retention in HIV Care Among HIV-Positive Men Who Have Sex With Men in Peru (WELTEL PERU)
Source: ClinicalTrials.gov · Last updated 30 May 2025
Brief summary (registry, in English)
We will use a web-based system in order to deliver a text messaging-based intervention and assess the efficacy to increase retention in HIV care among HIV+ gay men in Peru.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 208 (actual)
- First submitted
- 26 Jan 2022
- Start date
- 31 Jan 2022
- Primary completion date
- 12 May 2024
- Lead sponsor
- Universidad Peruana Cayetano Heredia
- Diseases
- HIV
- NCT number
- NCT05227417
What you commit to
- Study type: Interventional
- Participants enrolled: 208
- From 31 Jan 2022 to the primary completion date, 12 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\) Be enrolled in an interventional trial using text messages.
Who the study is looking for
- Be men who have sex with men;
- Be 18 years or older;
- Have been diagnosed HIV positive;
- Own a cell phone which can send and receive text messages;
- Reside in Lima, Peru;
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Cayetano Heredia Coordinator of this site? Confirm its status | Lima | Peru | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.